Is Kiromic Biopharma Inc (KRBP) a Poor Choice in the Healthcare Sector?

Thursday, October 28, 2021 10:04 AM | InvestorsObserver Analysts

Mentioned in this article

Is Kiromic Biopharma Inc (KRBP) a Poor Choice in the Healthcare Sector?

The 4 rating InvestorsObserver gives to Kiromic Biopharma Inc (KRBP) stock puts it near the bottom of the Healthcare sector. In addition to scoring higher than 0 percent of stocks in the Healthcare sector, KRBP’s 4 overall rating means the stock scores better than 4 of all stocks.

KRBP has an Overall Score of 4. Find out what this means to you and get the rest of the rankings on KRBP!

See Full KRBP Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 4 would rank higher than 4 percent of all stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Kiromic Biopharma Inc Stock Today?

Kiromic Biopharma Inc (KRBP) stock is trading at $1.96 as of 10:04 AM on Thursday, Oct 28, a gain of $0.11, or 5.95% from the previous closing price of $1.85. The stock has traded between $1.86 and $1.98 so far today. Volume today is less active than usual. So far 42,720 shares have traded compared to average volume of 627,182 shares. Click Here to get the full Stock Report for Kiromic Biopharma Inc stock.